Christoph Iven
Head of Corporate Credit Management
Bayer, Germany
- Industry:
- Pharmaceuticals
- Annual turnover:
- €35bn
- Treasury staff:
- 40
- Treasury structure:
- Centralised
- TMS:
- Yes
- Cross-border pooling:
- Yes
- Cash rich or debt:
- Debt
Speaker profile
Christoph is working within Corporate Credit Management since 2005, heading the department since 2009. In addition, he has also been responsible for Receivables Management within the WoC-project of the Group and is responsible for Bank Risk Management. He is vice chairman of the work-group “Credit Management” of the German association of chemical corporates (VCI). Before joining the Finance-organisation he was heading several SAP-projects within Bayer. After receiving his MBA at University Trier, he started at Bayer in 1996.
Corporate profile
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. The company’s products and services are designed to benefit people and improve their quality of life. At the same time Bayer creates value through innovation, growth and high earning power. The Group is committed to the principles of sustainable development and to its role as a socially and ethically responsible corporate citizen. Economy, ecology and social responsibility are corporate policy objectives of equal rank. In fiscal 2010, Bayer employed 111,400 people and had sales of €35 billion. Capital expenditures amounted to €1.6 billion, R&D expenses to €3.1 billion.
















